In 2023, the total market for self-medication amounted to 986 million euros. When looking at the product segments, the revenues for cough and cold products totaled around 232 million euros, whereas the revenues of products against pain amounted to approximately 202 million euros.
Self-medication revenues in the Netherlands from 2021 to 2023, by product segment
(in million euros)
Characteristic
2021
2022
2023
Total market
841
911.6
986
Cough and cold
170.7
219.3
232.4
Pain relief
169.4
188.5
202.4
Vitamins/minerals
179.6
174.1
193.2
Skin and hair
79.8
82.1
88.9
Digestion preparations
63.5
69.1
76.6
Urogenital care and reproduction
39.2
40.3
43.8
Other
138.8
138.1
148.7
Created with Highcharts 7.2.2Revenue in million euros986986232.4232.4202.4202.4193.2193.288.988.976.676.643.843.8148.7148.7911.6911.6219.3219.3188.5188.5174.1174.182.182.169.169.140.340.3138.1138.1841841170.7170.7169.4169.4179.6179.679.879.863.563.539.239.2138.8138.8202120222023Total marketCough and coldPain reliefVitamins/mineralsSkin and hairDigestion preparationsUrogenital care and reproductionOther
01002003004005006007008009001,0001,100
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
Neprofarm. (April 15, 2024). Self-medication revenues in the Netherlands from 2021 to 2023, by product segment (in million euros) [Graph]. In Statista. Retrieved April 26, 2025, from https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/
Neprofarm. "Self-medication revenues in the Netherlands from 2021 to 2023, by product segment (in million euros)." Chart. April 15, 2024. Statista. Accessed April 26, 2025. https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/
Neprofarm. (2024). Self-medication revenues in the Netherlands from 2021 to 2023, by product segment (in million euros). Statista. Statista Inc.. Accessed: April 26, 2025. https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/
Neprofarm. "Self-medication Revenues in The Netherlands from 2021 to 2023, by Product Segment (in Million Euros)." Statista, Statista Inc., 15 Apr 2024, https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/
Neprofarm, Self-medication revenues in the Netherlands from 2021 to 2023, by product segment (in million euros) Statista, https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/ (last visited April 26, 2025)
Self-medication revenues in the Netherlands from 2021 to 2023, by product segment (in million euros) [Graph], Neprofarm, April 15, 2024. [Online]. Available: https://www.statista.com/statistics/716348/revenue-of-self-care-medicines-in-the-netherlands-by-product-segment/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.